This study tests a new treatment for women whose ovarian cancer has come back. It combines chemotherapy placed directly into the abdomen with two immunotherapy drugs given through a vein. The goal is to see if this approach can shrink or eliminate tumors. The study involves 24 pa…
Phase: PHASE1, PHASE2 • Sponsor: Robert Edwards • Aim: Disease control
Last updated May 18, 2026 12:07 UTC